Loading the section…

ACH: financial statements from SEC — TradeAlmanac

ACH

Accendra Health, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31/12/2025	31/12/2024
Revenue	2.76B	2.68B
Cost of revenue	1.47B	1.40B
Gross profit	—	2.22B
Selling, general and administrative	1.07B	1.08B
Operating income	27M	−218M
Interest expense	—	144M
Pre-tax income	−102M	−330M
Income tax	729,000	21M
Net income	−1.10B	−363M
Earnings per share	−14.31	−4.73
Earnings per share, diluted	−14.31	−4.73

Balance sheet

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	337M	282M	33M	38M	59M	28M	75M	273M
Inventory	65M	74M	64M

Cash flow

Metric	31/12/2025	31/12/2024
Operating cash flow	−102M	161M
Depreciation and amortisation	215M	181M
Share-based compensation	13M	17M
Capital expenditure	191M	170M
Investing cash flow	144M	−117M
Share buybacks	10M

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator